Result of AGM
GENinCode Plc announced that all resolutions were duly passed at its Annual General Meeting held on July 1, 2026. The company, focused on the prevention of cardiovascular disease and ovarian cancer through predictive genetics, will post the voting results on its website later today.
Select text to share a quote on X · sign in to keep highlights & notes in your GENI notes
Oxford, UK. GENinCode Plc (AIM: GENI), the predictive genetics company focused on the prevention of cardiovascular disease and ovarian cancer, announces that at the Annual General Meeting held earlier today, all resolutions were duly passed.
A copy of the voting results can be found on the website later today here.
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.